Clinical trial
Endometrial Safety of a Low Dose of Vagifem® in Postmenopausal Women With…
NCT00431132 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00431132 |
|---|---|
| Title | Endometrial Safety of a Low Dose of Vagifem® in Postmenopausal Women With Atrophic Vaginitis |
| Official title | A 12 Month, Open-label, Multi-center Trial to Investigate the Endometrial Safety of Vagifem Low Dose (10ug 17beta-estradiol Vaginal Tablet) in Postmenopausal Women With Atrophic Vaginitis Symptoms |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Menopause, Postmenopausal Vaginal Atrophy |
| Intervention type | Drug |
| Interventions | estradiol, 10 mcg |
| Enrollment | 336 |
| Start date | Jan 1, 2007 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Feb 5, 2007 |
| Last update posted | Mar 15, 2017 |
| Countries | Czechia, Denmark, Finland, France, Hungary, Norway, Sweden |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: